Wealthcare Advisory Partners’s Schwab Fundamental Emerging Markets Large Company Index ETF FNDE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-1,040
Closed -$32K – 998
2021
Q1
$32K Buy
+1,040
New +$31.2K ﹤0.01% 1030
2020
Q2
– Sell
-19,331
Closed -$397K – 687
2020
Q1
$397K Sell
19,331
-1,861
-9% -$48.8K 0.06% 183
2019
Q4
$632K Buy
21,192
+1,697
+9% +$48.8K 0.08% 144
2019
Q3
$534K Buy
19,495
+2,522
+15% +$69.9K 0.08% 142
2019
Q2
$488K Buy
16,973
+10,926
+181% +$306K 0.08% 147
2019
Q1
$168K Buy
6,047
+6,036
+54,873% +$168K 0.03% 263
2018
Q4
$0 Buy
+11
New +$298 ﹤0.01% 1223
2018
Q1
– Sell
-270
Closed -$8K – 1135
2017
Q4
$8K Hold
270
– – ﹤0.01% 713
2017
Q3
$8K Buy
+270
New +$7.62K ﹤0.01% 583

Other funds holding FNDE

Wealthcare Advisory Partners's FNDE Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Schwab Fundamental Emerging Markets Large Company Index ETF (FNDE) in Q2 2021, closing a stake of 1,040 shares — an estimated $32K sold.

Wealthcare Advisory Partners first reported a position in FNDE in Q3 2017 and held it in 9 quarters. The position peaked at $632K in Q4 2019. 225 funds tracked by Wall St. Rank hold FNDE as of Q2 2021.

  • Wealthcare Advisory Partners reported no remaining Schwab Fundamental Emerging Markets Large Company Index ETF position as of Q2 2021 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 1,040 Schwab Fundamental Emerging Markets Large Company Index ETF shares in Q2 2021, an estimated $32K.
  • Wealthcare Advisory Partners first reported a position in Schwab Fundamental Emerging Markets Large Company Index ETF in Q3 2017 and held it in 9 quarters.
  • Wealthcare Advisory Partners's Schwab Fundamental Emerging Markets Large Company Index ETF position peaked at $632K in Q4 2019.
  • 225 funds tracked by Wall St. Rank held Schwab Fundamental Emerging Markets Large Company Index ETF as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.